Deciphera Pharmaceuticals (DCPH) Misses Q4 EPS by 18c

February 8, 2022 4:13 PM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q4 EPS of ($1.51), $0.18 worse than the analyst estimate of ($1.33). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $23.29 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities